Peter Soliz

VisionQuest Biomedical, Inc. develops and delivers innovative artificial intelligence-based imaging technologies that increase access to healthcare for those who need it the most. VisionQuest is based in Albuquerque, NM and is applying retinal screening to the detection of malarial retinopathy in the sub-Saharan country of Malawi. VisionQuest's focus is on developing AI techniques that can be used by healthcare professionals to evaluate digital medical photographs, specifically retinal images that show evidence of diabetic retinopathy and other pathologies. The company has established a network of clinics to study computer-based detection of retinal pathologies and its Eyestar software is used to screen patients for diabetic retinopathy. The company was founded in 2007 by Simon Barriga and Peter Soliz, with Soliz serving as CEO since then.

VisionQuest Biomedical, Inc. develops and delivers innovative artificial intelligence-based imaging technologies that increase access to healthcare for those who need it the most. VisionQuest is based in Albuquerque, NM and is applying retinal screening to the detection of malarial retinopathy in the sub-Saharan country of Malawi. VisionQuest's focus is on developing AI techniques that can be used by healthcare professionals to evaluate digital medical photographs, specifically retinal images that show evidence of diabetic retinopathy and other pathologies. The company has established a network of clinics to study computer-based detection of retinal pathologies and its Eyestar software is used to screen patients for diabetic retinopathy. The company was founded in 2007 by Simon Barriga and Peter Soliz, with Soliz serving as CEO since then.